62,734
edits
Changes
no edit summary
|-
| 2013 || || || Vaccine approval || The United States [[wikipedia:FDA|FDA]] approves influenza vaccine ''Flublok'' ([[wikipedia:Protein Sciences|Protein Sciences]]), developed through recombinant DNA technology.<ref>{{cite web|title=FDA Approves Flublok Quadrivalent Flu Vaccine|url=http://www.medscape.com/viewarticle/870201|website=medscape.com|accessdate=31 May 2018}}</ref> ||
|-
| 2014 || October 29 || Serogroup B meningococcal disease || Vaccine approval || "FDA approved the use of Trumenba in the U.S. to prevent serogroup B meningococcal disease."<ref>{{cite web |title=Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research (CBER) Division of Epidemiology (DE) |url=https://www.fda.gov/media/111536/download |website=fda.gov |accessdate=3 June 2020}}</ref> ||
|-
| 2014 || December 10 || {{w|Human papillomavirus infection}} || Vaccine approval || "FDA approved the use of Gardasil 9 (Merck) 9-valent HPV vaccine in the U.S."<ref>{{cite web |title=Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices |url=https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm#:~:text=9vHPV%20was%20approved%20by%20the,through%2015%20years%20(3). |website=cdc.gov |accessdate=2 June 2020}}</ref> ||
